Literature DB >> 8923001

A repeated element in the regulatory region of the MNK gene and its deletion in a patient with occipital horn syndrome.

B Levinson1, R Conant, R Schnur, S Das, S Packman, J Gitschier.   

Abstract

Occipital horn syndrome (OHS), an X-linked connective tissue disorder, has recently been shown to result from mutations in the Menkes disease gene (MNK), which encodes a copper-transporting ATPase. By Southern analysis we detected a small deletion in a region 5' to the MNK gene in one patient with OHS. Genomic clones from an unaffected individual were isolated and sequenced, revealing three tandem 98 bp repeats situated upstream of the reported transcription start site, and analysis of the patient's DNA showed a deletion of one of the repeats. The deletion is likely to be responsible for the disease in this patient, as it was not observed in 110 unaffected individuals analyzed, and no other mutation in the patient was detected by RT-PCR and chemical cleavage mismatch analysis or by cDNA sequence analysis. The deletion is associated with a dramatic decrease in expression of a chloramphenicol acetyltransferase reporter gene, implicating the repeat sequences in regulation of MNK expression, although a quantitative analysis of MNK mRNA from a cell line derived from the patient shows no detectable reduction. Other experiments revealed no effect on the site of transcription initiation, termination or on splicing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923001     DOI: 10.1093/hmg/5.11.1737

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.

Authors:  S L Dagenais; A N Adam; J W Innis; T W Glover
Journal:  Am J Hum Genet       Date:  2001-06-26       Impact factor: 11.025

2.  A C2055T transition in exon 8 of the ATP7A gene is associated with exon skipping in an occipital horn syndrome family.

Authors:  N Ronce; M P Moizard; L Robb; A Toutain; L Villard; C Moraine
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

Review 3.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

4.  Pamidronate treatment improves bone mineral density in children with Menkes disease.

Authors:  S Kanumakala; A Boneh; M Zacharin
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

5.  Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome.

Authors:  L B Møller; Z Tümer; C Lund; C Petersen; T Cole; R Hanusch; J Seidel; L R Jensen; N Horn
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

6.  Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.

Authors:  A S Payne; E J Kelly; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 7.  Menkes disease: underlying genetic defect and new diagnostic possibilities.

Authors:  Z Tümer; N Horn
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  A comparison of the mutation spectra of Menkes disease and Wilson disease.

Authors:  Gloria Hsi; Diane W Cox
Journal:  Hum Genet       Date:  2003-10-25       Impact factor: 4.132

9.  Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion.

Authors:  Andrew K Kwegyir-Afful; Robert D Bruno; Puranik Purushottamachar; Francis N Murigi; Vincent C O Njar
Journal:  FEBS J       Date:  2016-10-01       Impact factor: 5.542

10.  A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype.

Authors:  Maria Teresa Bonati; Federico Verde; Uros Hladnik; Paola Cattelan; Luca Campana; Chiara Castronovo; Nicola Ticozzi; Luca Maderna; Claudia Colombrita; Sergio Papa; Paolo Banfi; Vincenzo Silani
Journal:  Mol Genet Metab Rep       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.